Stage IV Melanoma: Completely Resectable Patients are Scarce

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.20, Iss.7, 2013-07, pp. : 2352-2356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients

By Atzpodien Jens Morawek Lars Fluck Michael Reitz Martina

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 901-905

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients

By Atzpodien Jens

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 685-688

Springer Publishing Company

Access to resources Recommend Favorite

Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate

By Vilella R. Benítez D. Milà J. Lozano M. Vilana R. Pomes J. Tomas X. Costa J. Vilalta A. Malvehy J. Puig S. Mellado B. Martí R. Castel T.

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 651-658

Springer Publishing Company

Access to resources Recommend Favorite

A phase 2, multicenter, open‐label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 643-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5‐fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO‐07 study

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 721-731

John Wiley & Sons Inc

Access to resources Recommend Favorite